These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6406053

  • 1. Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.
    Klippert PJ, Hulshoff A, Mingels MJ, Hofman G, Noordhoek J.
    Cancer Res; 1983 Jul; 43(7):3160-4. PubMed ID: 6406053
    [Abstract] [Full Text] [Related]

  • 2. First-pass metabolism of pentamethylmelamine in the rat liver.
    Klippert PJ, Hulshoff A, Hofman GA, Noordhoek J.
    Cancer Res; 1985 Mar; 45(3):983-6. PubMed ID: 3918792
    [Abstract] [Full Text] [Related]

  • 3. Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans.
    Ames MM, Powis G, Kovach JS, Eagan RT.
    Cancer Res; 1979 Dec; 39(12):5016-21. PubMed ID: 115586
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits.
    Gordon IL, Kar R, Opfell RW, Wile AG.
    Cancer Res; 1987 Oct 01; 47(19):5070-3. PubMed ID: 3113728
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
    Broggini M, Colombo T, D'Incalci M, Donnelli MG, Gescher A, Garattini S.
    Cancer Treat Rep; 1981 Oct 01; 65(7-8):669-72. PubMed ID: 6788370
    [Abstract] [Full Text] [Related]

  • 6. In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.
    Klippert PJ, Littel RJ, Noordhoek J.
    J Pharmacol Exp Ther; 1983 Apr 01; 225(1):153-7. PubMed ID: 6834267
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M, Ahr HJ, Beckermann B, Bühner K, Siefert HM, Steinke W, Wünsche C, Hirayama M.
    Arzneimittelforschung; 1997 Aug 01; 47(8):928-38. PubMed ID: 9296279
    [Abstract] [Full Text] [Related]

  • 14. Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat.
    Knodell RG, Spector MH, Brooks DA, Keller FX, Kyner WT.
    Gastroenterology; 1980 Dec 01; 79(6):1211-6. PubMed ID: 6777235
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS, Lee MG.
    Drug Metab Dispos; 1999 Feb 01; 27(2):221-6. PubMed ID: 9929506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
    Bramer SL, Au JL, Wientjes MG.
    J Pharmacol Exp Ther; 1993 May 01; 265(2):731-8. PubMed ID: 8496819
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY, Okochi H, Huang Y, Benet LZ.
    Drug Metab Dispos; 2006 Jul 01; 34(7):1175-81. PubMed ID: 16624870
    [Abstract] [Full Text] [Related]

  • 20. Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamine.
    Paolini A, D'Incalci M.
    Cancer Treat Rep; 1986 Apr 01; 70(4):513-6. PubMed ID: 3084083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.